CLEXANE enoxaparin sodium 60mg/0.6mL injection syringe with automatic safety lock system Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clexane enoxaparin sodium 60mg/0.6ml injection syringe with automatic safety lock system

sanofi-aventis australia pty ltd - enoxaparin sodium, quantity: 60 mg - injection, solution - excipient ingredients: water for injections; nitrogen - prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery. prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness. prevention of thrombosis in extra-corporeal circulation during haemodialysis. treatment of established deep vein thrombosis. treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin. treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).

CLEXANE [Clexane] Litauen - litauisk - SMCA (Valstybinė vaistų kontrolės tarnyba)

clexane [clexane]

sanofi-aventis lietuva, uab - enoksaparino natrio druska - injekcinis tirpalas - 10000 tv (100 mg)/1 ml; 6000 tv (60 mg)/0,6 ml; 4000 tv (40 mg)/0,4 ml; 2000 tv (20 mg)/0,2 ml; 8000 tv (80 mg)/0,8 ml - enoxaparin

CLEXANE FORTE enoxaparin sodium 150mg/1mL injection syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clexane forte enoxaparin sodium 150mg/1ml injection syringe

sanofi-aventis australia pty ltd - enoxaparin sodium, quantity: 150 mg - injection, solution - excipient ingredients: nitrogen; water for injections - prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery. prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness. prevention of thrombosis in extra-corporeal circulation during haemodialysis. treatment of established deep vein thrombosis. treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin. treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).

CLEXANE FORTE enoxaparin sodium 120mg/0.8mL injection syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clexane forte enoxaparin sodium 120mg/0.8ml injection syringe

sanofi-aventis australia pty ltd - enoxaparin sodium, quantity: 120 mg - injection, solution - excipient ingredients: water for injections; nitrogen - prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery. prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness. prevention of thrombosis in extra-corporeal circulation during haemodialysis. treatment of established deep vein thrombosis. treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin. treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).

CLEXANE enoxaparin sodium 100mg/1mL injection syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clexane enoxaparin sodium 100mg/1ml injection syringe

sanofi-aventis australia pty ltd - enoxaparin sodium, quantity: 100 mg - injection, solution - excipient ingredients: water for injections; nitrogen - prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery. prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness. prevention of thrombosis in extra-corporeal circulation during haemodialysis. treatment of established deep vein thrombosis. treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin. treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).

CLEXANE enoxaparin sodium 80mg/0.8mL injection syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clexane enoxaparin sodium 80mg/0.8ml injection syringe

sanofi-aventis australia pty ltd - enoxaparin sodium, quantity: 80 mg - injection, solution - excipient ingredients: water for injections; nitrogen - prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery. prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness. prevention of thrombosis in extra-corporeal circulation during haemodialysis. treatment of established deep vein thrombosis. treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin. treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).

CLEXANE enoxaparin sodium 60mg/0.6mL injection syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clexane enoxaparin sodium 60mg/0.6ml injection syringe

sanofi-aventis australia pty ltd - enoxaparin sodium, quantity: 60 mg - injection, solution - excipient ingredients: water for injections; nitrogen - prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery. prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness. prevention of thrombosis in extra-corporeal circulation during haemodialysis. treatment of established deep vein thrombosis. treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin. treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).

CLEXANE enoxaparin sodium 20mg/0.2mL injection syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clexane enoxaparin sodium 20mg/0.2ml injection syringe

sanofi-aventis australia pty ltd - enoxaparin sodium, quantity: 20 mg - injection, solution - excipient ingredients: water for injections; nitrogen - prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery. prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness. prevention of thrombosis in extra-corporeal circulation during haemodialysis. treatment of established deep vein thrombosis. treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin. treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).

CLEXANE enoxaparin sodium 40mg/0.4mL injection syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clexane enoxaparin sodium 40mg/0.4ml injection syringe

sanofi-aventis australia pty ltd - enoxaparin sodium, quantity: 40 mg - injection, solution - excipient ingredients: water for injections; nitrogen - prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery. prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness. prevention of thrombosis in extra-corporeal circulation during haemodialysis. treatment of established deep vein thrombosis. treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin. treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).

CLEXANE 40 INJECTION Sør-Afrika - engelsk - South African Health Products Regulatory Authority (SAHPRA)

clexane 40 injection

sanofi-aventis south africa (pty) ltd - injection - see ingredients - each 0,4 ml solution contains enoxaparin 40 mg